This Monday may well mark a fundamental change in our society. A huge claim, but bear with me. For the first time, weight-loss pills containing semaglutide – the active ingredient that transformed obesity treatment through injectable drugs such as Ozempic – will be available in pill form through UK pharmacies and online providers. The level of interest has been described as “significant” by the pharmacy industry, with tens of thousands registering their interest.

This is not simply the launch of another medicine. It is potentially the start of a profound shift in how Britain thinks about weight, health and personal responsibility. The implications stretch beyond medicine cabinets and GP surgeries. They could reshape everything from supermarkets and restaurants to pubs, gyms, employers and, ultimately, the NHS.

For decades, wanting to lose weight has come entailed familiar advice: eat less, move more.........

© iNews